Introduction Extractables & Leachables (E&L) Testing for Veterinary Drug Products is an essential safety and regulatory requirement designed to ensure […]
Introduction The design and implementation of a comparability exercise in biosimilar development represent the fundamental benchmark for demonstrating molecular similarity
Introduction The primary technical consideration when comparing NDSRIs with simple nitrosamines lies in understanding how differences in molecular complexity and
Introduction Peptide physicochemical characterization services establish the scientific basis required to confirm the molecular identity, therapeutic suitability, and regulatory compliance
Introduction Peptide-oligonucleotide conjugates (POCs) demand tightly controlled chemical, thermal, and physical conditions to preserve their structural integrity and biological functionality
Handling and Storage Best Practices for Peptide-Oligonucleotide Conjugates Read More »
Introduction: The role of PK/PD studies in biosimilar development has become one of the most closely watched questions in biologics
Introduction: Advanced Advancements in Peptide Impurity Identification and Characterization Services Peptide Impurity Identification and Characterization Services are specialized analytical solutions
Introduction Effective Residual Solvent Control in PLGA Microsphere Manufacturing relies on optimizing post-formulation solvent removal processes and confirming regulatory compliance
Introduction Nitrosamine Testing for Injectable Drug Products is a highly specialized analytical quality control procedure used to identify and quantify
Introduction: Nitrosamine testing for proton pump inhibitors has become a non-negotiable part of regulatory compliance for manufacturers of omeprazole, esomeprazole,
